StockData
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH) stock

AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3058% below fair value
$15.13−0.27 (-1.75%)

Close on Nov 18, 2026Market cap $2.03BP/E 6.6Yield –

Aurinia Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Aurinia Pharmaceuticals's revenue for the twelve months ending Sep 30, 2026 was $321.74M, up 21.0% year over year. For fiscal 2025 it was $283.06M, up 20.4% from the year before. The highest annual figure on record is $283.06M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$283.06M+20.4%
FY2024Dec 31, 2024$235.13M+34.0%
FY2023Dec 31, 2023$175.51M+31.0%
FY2022Dec 31, 2022$134.03M+193.9%
FY2021Dec 31, 2021$45.61M-9.0%
FY2020Dec 31, 2020$50.12M+15660.4%
FY2019Dec 31, 2019$318.00K-31.3%
FY2018Dec 31, 2018$463.00K+10.8%
FY2017Dec 31, 2017$418.00K+141.6%
FY2016Dec 31, 2016$173.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$83.70M+13.9%
Q2 FY2026Jun 30, 2026$83.22M+18.9%
Q1 FY2026Mar 31, 2026$77.71M+24.4%
Q4 FY2025Dec 31, 2025$77.11M+28.8%
Q3 FY2025Sep 30, 2025$73.47M+8.4%
Q2 FY2025Jun 30, 2025$70.01M+22.4%
Q1 FY2025Mar 31, 2025$62.47M+24.2%
Q4 FY2024Dec 31, 2024$59.87M+32.8%
Q3 FY2024Sep 30, 2024$67.77M+24.3%
Q2 FY2024Jun 30, 2024$57.19M+37.8%
Q1 FY2024Mar 31, 2024$50.30M+46.2%
Q4 FY2023Dec 31, 2023$45.10M+58.6%
Q3 FY2023Sep 30, 2023$54.52M-2.3%
Q2 FY2023Jun 30, 2023$41.49M+47.2%
Q1 FY2023Mar 31, 2023$34.41M+59.1%
Q4 FY2022Dec 31, 2022$28.44M+21.5%
Q3 FY2022Sep 30, 2022$55.78M+280.3%
Q2 FY2022Jun 30, 2022$28.19M+325.8%
Q1 FY2022Mar 31, 2022$21.63M+2266.0%
Q4 FY2021Dec 31, 2021$23.40M-53.2%
Q3 FY2021Sep 30, 2021$14.67M+50475.9%
Q2 FY2021Jun 30, 2021$6.62M+22727.6%
Q1 FY2021Mar 31, 2021$914.00K+2946.7%
Q4 FY2020Dec 31, 2020$50.03M+172417.2%
Q3 FY2020Sep 30, 2020$29.00K-87.4%
Q2 FY2020Jun 30, 2020$29.00K0.0%
Q1 FY2020Mar 31, 2020$30.00K0.0%
Q4 FY2019Dec 31, 2019$29.00K–
Q3 FY2019Sep 30, 2019$230.00K–
Q2 FY2019Jun 30, 2019$29.00K–
Q1 FY2019Mar 31, 2019$30.00K–

More Aurinia Pharmaceuticals figures

See a number that looks wrong?